A Phase II Evaluation of Clofazimine plus Doxorubicin in Advanced, Unresectable Primary Hepatocellular Carcinoma

Publisher： Karger

E-ISSN： 1423-0232|57|3|232-235

ISSN： 0030-2414

Source： Oncology, Vol.57, Iss.3, 1999-10, pp. : 232-235

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of Bevacizumab plus Erlotinib for Advanced Hepatocellular Carcinoma and Predictors of Outcome: Final Results of a Phase II Trial

By  

Oncology, Vol. 82, Iss. 2, 2012-02 ,pp. : 67-74

Karger

Access to resources Recommend Favorite

Randomized, Phase II Study Comparing Interferon Combined with Hepatic Arterial Infusion of Fluorouracil plus Cisplatin and Fluorouracil Alone in Patients with Advanced Hepatocellular Carcinoma

By  

Oncology, Vol. 81, Iss. 5-6, 2011-11 ,pp. : 281-290

Karger

Access to resources Recommend Favorite

Transarterial Chemoembolisation Using Doxorubicin Beads for Unresectable Hepatocellular Carcinoma

By  

Oncology Research and Treatment, Vol. 33, Iss. 1-2, 2010-01 ,pp. : 5-6

Karger

Access to resources Recommend Favorite

A Randomized Phase II Study of Drug-Eluting Beads versus Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma

By  

Oncology Research and Treatment, Vol. 34, Iss. 7, 2011-06 ,pp. : 368-376

Karger

Access to resources Recommend Favorite

Phase II Trial of Docetaxel Therapy in Patients with Advanced Hepatocellular Carcinoma

By  

Oncology, Vol. 70, Iss. 2, 2006-05 ,pp. : 154-158

Karger

Access to resources Recommend Favorite